Activities of Atazanavir (BMS-232632) against a Large Panel of Human Immunodeficiency Virus Type 1 Clinical Isolates Resistant to One or More Approved Protease Inhibitors

Benzer Materyaller

• In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632
  Yazar:: Gong, Yi-Fei, ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents
  Yazar:: Robinson, Brett S., ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• A Mutation in Human Immunodeficiency Virus Type 1 Protease, N88S, That Causes In Vitro Hypersensitivity to Amprenavir
  Yazar:: Ziermann, Rainer, ve diğerleri
  Baskı/Yayın Bilgisi: (2000)
• Atazanavir Signature I50L Resistance Substitution Accounts for Unique Phenotype of Increased Susceptibility to Other Protease Inhibitors in a Variety of Human Immunodeficiency Virus Type 1 Genetic Backbones
  Yazar:: Weinheimer, S., ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir
  Yazar:: Klei, Herbert E., ve diğerleri
  Baskı/Yayın Bilgisi: (2007)